Bangladesh to contribute $50,000 to develop COVID-19 vaccine



Bangladesh will contribute 50,000 US dollar to ‘Global Citizen’ fund to support development COVID-19 vaccines, reports BSS.

“I’m pleased to announce a contribution of US$50,000 to support development and availability of safe and effective vaccine, more importantly equitable access to health care and to combat that this proportionate impact of COVID-19 only marginalize communities,’ said Foreign Minister AK Abdul Momen.

The foreign minister was virtually addressing the ‘Global Goal: Unite for Our Future – the Summit’ organised by European Commission and Global Citizen on Saturday to create an additional funding to develop and deploy coronavirus vaccines, tests and treatments.

Momen said Bangladesh has always attached importance to the principles of equity, fairness and national ownership.

“This commitment guides our support for this resource mobilization effort towards promoting equitable access to services for those most in need anywhere in the world so no one is left behind,” he said.

Momen said Prime Minister Sheikh Hasina remains firm and focused on the front of this unforeseen crisis and ‘We shall continue to remain true to our International obligations while anticipating responsible conduct from our relevant partners in mitigating this accidental shock’.

European Commission president Ursula Gertrud von der Leyen hosted the ‘Global Goal: Unite for Our Future – the Summit’ that included interventions by world leaders as well as international advocates, artists and activists.The ‘Global Goal: Unite For Our Future’ campaign was launched by the European Commission and the international advocacy organisation Global Citizen on May 28 and so far mobilized 6.9 billion US dollar – $1.5 billion in cash grants and $5.4 billion in loans and guarantees – to combat the disproportionate impact of covid-19 on vulnerable and disadvantaged communities.

Comments are closed.

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More